Moximed Completes Enrollment of KineSpring System US SOAR Study in Patients With Knee Osteoarthritis

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAYWARD, Calif.--(BUSINESS WIRE)--Moximed®, Inc. announced today that enrollment has been completed in its US-based SOAR clinical study. Patients enrolled in the SOAR clinical study were treated with the KineSpring® System, an implantable medical spring that works by unloading weight in the knee joints of patients with osteoarthritis (OA).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC